Burden and Impact of Infectious Complications After Allogeneic Hematopoietic Cell Transplantation in Older Patients: A GETH-TC Study.

Authors

Sara Fernández-Luis, Mónica Baile González, Alejandro Avendaño, Cristina Alburquerque-Prieto, Lucrecia Yáñez San Segundo, María Queralt Salas, Paula Sánchez, Alberto Doblas, Marta Luque, Candela Ceballos, Nerea Arratibel, María José Jiménez, María Huguet Mas, Clara Aparicio, Carmen Martín Calvo, Ana Pilar González-Rodriguez, Lucía García Mañó, Leyre Bento, Andrés Sánchez Salinas, Lucía García Tomás, Inmaculada Heras, Sara Villar, José Rifón, Irene García-Cadenas

Published in

Transplantation and cellular therapy. Aug 13, 2026. Epub Aug 13, 2026.

Abstract

Infectious complications remain a major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (allo-HCT). With the increasing use of allo-HCT in older adults, the burden and clinical impact of infections in this population remain poorly characterized.
To characterize the epidemiology of microbiologically documented infections during the first year after allo-HCT in patients aged ≥65 years and to identify risk factors for infectious complications.
This retrospective multicenter study included consecutive patients aged ≥ 65 years undergoing a first allo-HCT in 13 Spanish centers between 2011 and 2023. Microbiologically documented infections occurring within the first year post-transplant, or until relapse or death, were analyzed. Cumulative incidence (CI), infection density, and multivariable models were used to identify risk factors and assess clinical outcomes.
Overall, 568 of 726 allo-HCT recipients (78.2%) experienced ≥ 1 infectious episode, with an overall infection density of 8.77 per 1,000 patient-days. Viral and bacterial infections were most common, affecting 60.6% and 54.8% of patients, respectively. At 1 year, the CI of bacterial infection was 53.6% (density 4.31 per 1,000 patient-days), invasive fungal disease (IFD) 11.7% (density 0.47 per 1,000 patient-days), and CMV infection 44.0%. Infection-related mortality at 1 year was 12.4%, mainly driven by Gram-negative bacterial and Aspergillus infections. The occurrence of any infectious episode was independently associated with inferior overall survival (OS; HR 1.6, 95% CI 1.3-2.1) and higher non-relapse mortality (NRM; HR 3.4, 95% CI 2.3-4.9). Bacterial infections, IFD, and CMV infection were independently associated with inferior OS and increased NRM. Across infection-specific multivariable analyses, poor functional status, haploidentical transplantation, and GvHD emerged as the principal determinants of infectious burden, whereas antibacterial prophylaxis and letermovir were protective.
In older allo-HCT recipients, infectious complications affected a large proportion of patients and have a substantial impact on survival. Functional status and donor type independently modulate susceptibility to infection, highlighting the need for refined risk stratification and tailored preventive strategies. Infection density may provide a useful complementary measure to better capture the burden of recurrent infectious events in this population.

PMID:
42595014
Bibliographic data and abstract were imported from PubMed on 14 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.